TRIDENT LIFELINE
Quarterly Results Analysis [Jun2026]
TRIDENT LIFELINE Quarterly Results
| Consolidated | Jun2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Dec2024 UnAudited |
Sep2024 Audited |
Jun2024 Audited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹34 Cr | ₹26 Cr | ₹31 Cr | ₹24 Cr | ₹12 Cr | ₹15 Cr | ₹13 Cr | ₹7 Cr |
| Expenses | ₹25 Cr | ₹21 Cr | ₹24 Cr | ₹18 Cr | ₹8 Cr | ₹11 Cr | ₹11 Cr | ₹6 Cr |
| Operating Income | ₹9 Cr | ₹5 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr |
| Other Income | ₹1 Cr | ₹5 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
| Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
| Profit Before Tax | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹1 Cr |
| Profit After Tax | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
| EPS | ₹4.22 | ₹3.61 | ₹4.27 | ₹2.66 | ₹2.42 | ₹2.69 | ₹1.99 | ₹0.94 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| TRIDENT LIFELINE | -0.2% | 6.7% | 5.6% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.7% | -1.4% | 21.7% |
| DIVIS LABORATORIES | 2% | 10.3% | 49.5% |
| TORRENT PHARMACEUTICALS | -0.4% | -0.5% | 38.6% |
| CIPLA | -0.5% | -2.5% | -10.2% |
| DR REDDYS LABORATORIES | -1.2% | 0% | -7.1% |
| MANKIND PHARMA | -1.5% | -3.3% | -4.6% |
| LUPIN | -0.6% | -9.4% | 13% |
| ZYDUS LIFESCIENCES | -3.2% | 2.9% | 19.2% |
TRIDENT LIFELINE Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 31.14 % |
| Y-o-Y | 185.09 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹34 Cr | 31.14 | |
| Dec2025 | ₹26 Cr | -17.95 | |
| Sep2025 | ₹31 Cr | 32.76 | |
| Jun2025 | ₹24 Cr | 99.59 | |
| Dec2024 | ₹12 Cr | -23.45 | |
| Sep2024 | ₹15 Cr | 17.45 | |
| Jun2024 | ₹13 Cr | 85.53 | |
| Dec2023 | ₹7 Cr | - | |
TRIDENT LIFELINE Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 67.07 % |
| Y-o-Y | 108.83 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹9 Cr | 67.07 | |
| Dec2025 | ₹5 Cr | -25.69 | |
| Sep2025 | ₹7 Cr | 32.73 | |
| Jun2025 | ₹5 Cr | 26.74 | |
| Dec2024 | ₹4 Cr | 0.62 | |
| Sep2024 | ₹4 Cr | 62.21 | |
| Jun2024 | ₹2 Cr | 75.42 | |
| Dec2023 | ₹1 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 27.40 % |
| Y-o-Y | -26.75 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 25.25% | 27.40 | |
| Dec2025 | 19.82% | -9.41 | |
| Sep2025 | 21.88% | -0.05 | |
| Jun2025 | 21.89% | -36.50 | |
| Dec2024 | 34.47% | 31.41 | |
| Sep2024 | 26.23% | 38.13 | |
| Jun2024 | 18.99% | -5.43 | |
| Dec2023 | 20.08% | - | |
TRIDENT LIFELINE Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 8.99 % |
| Y-o-Y | 98.28 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹5 Cr | 8.99 | |
| Dec2025 | ₹5 Cr | -8.70 | |
| Sep2025 | ₹5 Cr | 82.80 | |
| Jun2025 | ₹3 Cr | 9.00 | |
| Dec2024 | ₹3 Cr | -9.04 | |
| Sep2024 | ₹3 Cr | 75.45 | |
| Jun2024 | ₹2 Cr | 52.62 | |
| Dec2023 | ₹1 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -16.92 % |
| Y-o-Y | -30.46 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | 15.02 % | -16.92 | |
| Dec2025 | 18.08 % | 11.26 | |
| Sep2025 | 16.25 % | 37.71 | |
| Jun2025 | 11.8 % | -45.37 | |
| Dec2024 | 21.6 % | 18.81 | |
| Sep2024 | 18.18 % | 49.38 | |
| Jun2024 | 12.17 % | -17.77 | |
| Dec2023 | 14.8 % | - | |
TRIDENT LIFELINE Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 16.90 % |
| Y-o-Y | 74.38 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹4.22 | 16.90 | |
| Dec2025 | ₹3.61 | -15.46 | |
| Sep2025 | ₹4.27 | 60.53 | |
| Jun2025 | ₹2.66 | 9.92 | |
| Dec2024 | ₹2.42 | -10.04 | |
| Sep2024 | ₹2.69 | 35.18 | |
| Jun2024 | ₹1.99 | 111.70 | |
| Dec2023 | ₹0.94 | - | |
You may also like the below Video Courses